tbuckley/cabot-search huggingface dataset:
Abstract 12829: Sodium Excretion and Risk of Cardiovascular Disease: A 20-year Follow-up Study
Authors: Long Zhou, Jinzhuang Mai, Ying Li, Xiangmin Gao, Yong Wu, Min Guo, Xiaoqing Liu, Liancheng Zhao
Journal: Circulation (2016)

Introduction: Effects of sodium intake and cardiovascular (CV) events from prospective cohort studies have been conflicting. The present study aims to estimate the effect of sodium excretion on cardiovascular disease in Chinese population. Methods: Data from the PRC-USA Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology were used in the analyses, including 880 men and women ages 35-59 years at baseline from 4 urban and rural population samples in Beijing and Guangzhou of China. Three timed 8-hour overnight urine samples were collected for each participant; the average of 3 times urinary sodium measurements were used. The association of urinary sodium categorized by tertiles with CV events was tested by Cox proportional hazards multivariable models. Results: At baseline, the mean (SD) estimated 8-hour overnight excretion for sodium was 63.48 (33.66) mmol. After a median follow-up of 20.25 years, the total CV outcome occurred in 64 (7.3%) participants, including 15 coronary heart disease (CHD) events (acute myocardial infarction, sudden cardiac death, or CHD death) and 52 stroke. From lowest (&lt;44.28 mmol/8h) to highest (&gt;=72.28 mmol/8h) tertile of sodium excretion, the cumulative incidence was 4.1%, 6.8%, and 10.9% for total CV events and 3.4%, 5.4%, and 8.9% for stroke. Compared with the lowest sodium excretion group, the Hazard Ratios (HRs) and 95% CI after adjustment for age, gender, site, type of work, smoke, alcohol drinking and serum total cholesterol for total CV outcome were 1.764 (0.853-3.647) and 2.745 (1.390-5.419) in middle (44.28-72.28 mmol/8h) and the highest sodium excretion groups, respectively. Furthermore, the HRs and 95% CI for stroke were 1.756 (0.789-3.912) and 2.737 (1.296-5.777) in middle and the highest sodium excretion groups, respectively. However, the association of sodium excretion with total CV outcome and stroke was not significant both in middle and the highest groups when we additionally adjusted for baseline systolic blood pressure. Conclusions: Higher urinary sodium excretion is associated with increased risk of CV events and stroke, but this relationship is not independent of baseline blood pressure levels.
Pyroptosis by caspase11/4‐gasdermin‐D pathway in alcoholic hepatitis in mice and patients
Authors: Elena Khanova, Raymond Wu, Wen Wang, Rui Yan, Yibu Chen, Samuel W. French, Cristina Llorente, Stephanie Q. Pan, Qihong Yang, Yuchang Li, Raul Lazaro, Charles Ansong, Richard D. Smith, Ramon Bataller, Timothy Morgan, Bernd Schnabl, Hidekazu Tsukamoto
Journal: Hepatology (2017)

Alcoholic hepatitis (AH) continues to be a disease with high mortality and no efficacious medical treatment. Although severe AH is presented as acute on chronic liver failure, what underlies this transition from chronic alcoholic steatohepatitis (ASH) to AH is largely unknown. To address this question, unbiased RNA sequencing and proteomic analyses were performed on livers of the recently developed AH mouse model, which exhibits the shift to AH from chronic ASH upon weekly alcohol binge, and these results are compared to gene expression profiling data from AH patients. This cross‐analysis has identified Casp11 ( CASP4 in humans) as a commonly up‐regulated gene known to be involved in the noncanonical inflammasome pathway. Immunoblotting confirms CASP11/4 activation in AH mice and patients, but not in chronic ASH mice and healthy human livers. Gasdermin‐D (GSDMD), which induces pyroptosis (lytic cell death caused by bacterial infection) downstream of CASP11/4 activation, is also activated in AH livers in mice and patients. CASP11 deficiency reduces GSDMD activation, bacterial load in the liver, and severity of AH in the mouse model. Conversely, the deficiency of interleukin‐18, the key antimicrobial cytokine, aggravates hepatic bacterial load, GSDMD activation, and AH. Furthermore, hepatocyte‐specific expression of constitutively active GSDMD worsens hepatocellular lytic death and polymorphonuclear leukocyte inflammation. Conclusion: These results implicate pyroptosis induced by the CASP11/4‐GSDMD pathway in the pathogenesis of AH. (H epatology 2018;67:1737‐1753).
OA 16.04 Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
Authors: D. Yue, S. Xu, Q. Wang, X. Li, Y. Shen, H. Zhao, C. Chen, W. Mao, W. Liu, J. Liu, L. Zhang, H. Ma, Q. Li, Y. Yang, Y. Liu, H. Chen, C. Wang
Journal: Journal of Thoracic Oncology (2017)
P3.03-002 Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
Authors: T. Yamada, J. Amann, A. Tanimoto, H. Taniguchi, T. Shukuya, S. Yano, K. Takayama, D. Carbone
Journal: Journal of Thoracic Oncology (2017)
P1.03-004 Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status
Authors: H. Kenmotsu, E. Iwama, Y. Goto, T. Harada, S. Tsumura, H. Sakashita, Y. Mori, N. Nakagaki, Y. Fujita, M. Seike, A. Bessho, M. Ono, A. Okazaki, H. Akamatsu, R. Morinaga, S. Ushijima, T. Shimose, S. Tokunaga, A. Hamada, N. Yamamoto, Y. Nakanishi, K. Sugio, I. Okamoto
Journal: Journal of Thoracic Oncology (2017)
La surveillance des infections invasives à méningocoques en République Tchèque
Authors: P Kriz
Journal: Eurosurveillance (2004)

En Republique Tcheque, la declaration en routine des infections invasives a meningocoques a ete mise en place depuis longtemps: les donnees de mortalite sont disponibles depuis 1921 et celles de morbidite depuis 1943. Les souches de Neisseria meningitidis conservees au Laboratoire national de reference des infections a meningocoques de Prague sont conservees depuis 1970, representant plus de 3500 souches provenant de cas d'infections invasives et de leurs contacts, de porteurs sains et de cas d'infections respiratoires. L'analyse de ces prelevements montre que la population touchee par ces infections en Republique Tcheque differe de celle observee en Europe occidentale. En 1993, L'incidence des infections a meningocoque de serogroupe C a augmente et est associee a l'emergence du complexe Neisseria meningitidis C, ST-11, ET-15/37 extremement virulent, responsable d'une augmentation de l'incidence des infections invasives a meningocoque,dont le pic a ete en 1995 (2,2/100 000). Une strategie vaccinale ciblant la population a plus haut risque pour ces infections invasives a meningocoque a ete mise en place dans le pays.
Alendronate and Hip Fracture in Patients Using Glucocorticoids
Authors: Rishi J. Desai, Jessica M. Franklin, Seoyoung C. Kim
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PL 02.04 SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial
Authors: B. Massuti, M. Cobo, M. Rodriguez-Paniagua, I. Ballesteros, T. Moran, R. Arrabal, J.L. Gonzalez Larriba, I. Barneto, Y. Wah Pun, J. de Castro Carpeño, S. Ponce-Aix, C. Baamonde, M.A. Muñoz, G. Lopez-Vivanco, J.J. Rivas de Andres, D. Isla, R. Lopez, J.M. Sanchez, J. Sánchez-Payá, R. Rosell
Journal: Journal of Thoracic Oncology (2017)
MA 11.09 Real World Data of Rebiopsy, Mutation Status, and Its Association with Plasma Genotyping after EGFR TKI Failure in NSCLC
Authors: M.H. Hong, B.C. Ahn, H.R. Kim, S.J. Heo, J.H. Kim, I.Y. Bang, R. Kim, H.W. Jung, H.J. Cho, H. Kim, H. Kim, B.C. Cho
Journal: Journal of Thoracic Oncology (2017)
Développement d'un réseau électronique européen pour les maladies transmissibles : le programme IDA-HSSCD
Authors: J Weinberg, H Nohynek, J Giesecke
Journal: Eurosurveillance (1997)

Le developpement de l'Union Europeenne (UE), bloc multinational ou les marchandises et les personnes circulent librement, a accentue les difficultes dans le domaine de la surveillance des maladies transmissibles liees aux echanges commerciaux et aux voyages internationaux. Face a cela, des collaborations dans la surveillance se sont developpees parmi les pays de l'UE. Elles ont reussi a identifier des epidemies qui impliquaient plusieurs pays (1-4).
DRES-04. DEVELOPMENT OF A CRISPR-CAS9D10A TARGETABLE, HIGH-COMPLEXITY, SINGLE-CELL BARCODING APPROACH FOR ISOLATION OF TREATMENT RESISTANT SUBCLONES FROM HETEROGENOUS MALIGNANT GLIOMAS
Authors: Ze-yan Zhang, Ravesanker Ezhilarasan, Yingwen Ding, Qianghu Wang, Jie Yang, Lihong Long, Roel Verhaak, Erik Sulman
Journal: Neuro-Oncology (2017)

Malignant gliomas are composed of heterogeneous cell populations and the clonal evolution of these cells is one of the key reasons for treatment resistance and tumor recurrence. A fundamental challenge in studying clonal evolution in these tumors is the difficulty in isolating the phenotype-associated (e.g. treatment resistant) sub-populations from the heterogeneous population. We developed an approach to individually barcode and isolate specific cell subpopulations using a CRISPR (clustered, regularly interspaced, short palindromic repeat)-Cas9D10A targetable, single-cell barcoding library with a complexity of 36 million unique barcodes. This approach enabled us to uniquely barcode > 1 million cells, identify enriching barcoded sub-populations following treatment and then isolate the resistant subpopulation using the subpopulation-specific barcode. Each barcode sequence carrying two guide RNAs so that CRISPR-Cas9D10A targeting can lead to “switching” (i.e. frameshift) of an EGFP (Enhanced Green Fluorescent Protein) reporter. Thus, targeted cells lose their EGFP signal and can be specifically isolated by cell sorting. Proof of principle studies showed that specific barcoding cells could be efficiently targeted to turn off EGFP and subpopulations isolated. Subsequent large-scale implementation of this approach has been performed to isolate resistant subpopulations following radiation and temozolomide. Our approach will lead to identification of the both pre-existing and acquired specific somatic genetic or epigenetic changes driving treatment resistance in patients with malignant gliomas.
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
Authors: Raul G. Nogueira, Ashutosh P. Jadhav, Diogo C. Haussen, Alain Bonafe, Ronald F. Budzik, Parita Bhuva, Dileep R. Yavagal, Marc Ribo, Christophe Cognard, Ricardo A. Hanel, Cathy A. Sila, Ameer E. Hassan, Monica Millan, Elad I. Levy, Peter Mitchell, Michael Chen, Joey D. English, Qaisar A. Shah, Frank L. Silver, Vitor M. Pereira, Brijesh P. Mehta, Blaise W. Baxter, Michael G. Abraham, Pedro Cardona, Erol Veznedaroglu, Frank R. Hellinger, Lei Feng, Jawad F. Kirmani, Demetrius K. Lopes, Brian T. Jankowitz, Michael R. Frankel, Vincent Costalat, Nirav A. Vora, Albert J. Yoo, Amer M. Malik, Anthony J. Furlan, Marta Rubiera, Amin Aghaebrahim, Jean-Marc Olivot, Wondwossen G. Tekle, Ryan Shields, Todd Graves, Roger J. Lewis, Wade S. Smith, David S. Liebeskind, Jeffrey L. Saver, Tudor G. Jovin
Journal: New England Journal of Medicine (2017)

The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume may benefit from late thrombectomy.
PDTM-08. STATINS SYNGERGIZE WITH SMOOTHENED INHIBITOR VISMODEGIB TO INHIBIT MEDULLOBLASTOMA GROWTH
Authors: Zeng-Jie Yang, Renata Gordon
Journal: Neuro-Oncology (2017)

Activation of the hedgehog (Hh) pathway is common in basal cell carcinoma (BCC) and it occurs in approximately 30% of medulloblastoma (MB), the most common malignant pediatric brain tumor. Here, we demonstrate increased biosynthesis of cholesterol, and a requirement for cholesterol, in maintaining the activity of Smoothened (Smo) in Hh pathway-associated MB (Hh-MB). Inhibition of cholesterol biosynthesis dramatically decreases Hh pathway activity and reduces proliferation of MB cells. Simvastatin, a commonly used inhibitor of cholesterol biosynthesis, significantly inhibited MB growth in vivo, and it functioned synergistically in combination with the approved Smo antagonist, vismodegib. Our studies demonstrate an indispensable role for cholesterol in Hh pathway signal transduction and in the growth of Hh-MB. Given the excellent safety profile, low cost and ready availability of cholesterol inhibitors, targeting cholesterol biosynthesis represents a promising strategy for treatment of Hh-MB and potentially other malignancies involving activation of the Hh pathway.
Re: Rita Faria, Marta O. Soares, Eldon Spackman, et al. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). Eur Urol 2018;73:23–30
Authors: Alberto Martini, Akriti Gupta, Shivaram Cumarasamy, Ash K. Tewari
Journal: European Urology (2017)
P2.03-002 Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
Authors: S. Igawa, Y. Sato, S. Kusuhara, S. Harada, M. Shirasawa, S. Kurahayashi, Y. Okuma, A. Sugimoto, K. Sugita, Y. Nakahara, S. Otani, T. Fukui, M. Yokoba, H. Mitsufuji, M. Kubota, M. Katagiri, J. Sasaki, N. Masuda
Journal: Journal of Thoracic Oncology (2017)
Maternal β-Blocker Use and Fetal Cardiac Anomalies
Authors: Elif Keskin-Arslan, Ali Akoz, Yusuf-Cem Kaplan
Journal: JAMA Internal Medicine (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
P1.08-004 Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
Authors: J. Sun, H.K. Kim, S. Lee, Y.C. Ahn, J. Kim, M. Ahn, J.I. Zo, Y.M. Shim, K. Park
Journal: Journal of Thoracic Oncology (2017)
Centro europeo para la prevención y el control de enfermedades (ECDC) y Organización Mundial de la Salud (OMS) : una misión común para mejorar la salud en Europa
Authors: M Danzon
Journal: Eurosurveillance (2004)

El ano 2005 sera un ano importante para la Salud Publica en Europa, con la inauguracion en Estocolmo en Mayo de 2005 del Centro europeo para la prevencion y el control de enfermedades (ECDC). La idea de un Centro europeo para el control de enfermedades estaba pendiente desde hace algunos anos, tras los optimos resultados obtenidos por el Centro de control de enfermedades (CDC) americano en Atlanta.
Foyer de salmonellose à Salmonella Enteritidis en Suède 2005-2006 – source présumée: les amandes
Authors: L Ledet Muller, M Hjertqvist, L Payne, H Pettersson, A Olsson, L Plym-Forshell, Y Andersson
Journal: Eurosurveillance (2007)

Au Canada et aux Etats-Unis, des epidemies passees de salmonellose a Salmonella Enteritidis ont ete associees a la consommation d’amandes. De decembre 2005 a aout 2006, 15 cas de salmonellose a Salmonella Enteritidis NST 3+ ont ete repertories en Suede.
Enzalutamide (E) vs abiraterone acetate (AA) in the treatment of metastatic, castration-resistant prostate cancer. Indirect comparisons and network meta-analysis for clinical practice
Authors: E. Bianchi, M. Fantini, S.L.V. Nicoletti, F. Drudi, E. Tamburini, C. Cherubini, C. Ridolfi, F. Montanari, A. Venturi, G. Pasini, D. Tassinari
Journal: Annals of Oncology (2017)
MNGI-13. FINAL ANALYSIS OF PHASE II COMBINING EVEROLIMUS AND OCTREOTIDE FOR PATIENTS WITH REFRACTORY AND DOCUMENTED PROGRESSIVE MENINGIOMA (CEVOREM)
Authors: Thomas Graillon, Marc Sanson, Matthieu Peyre, Hadrien Peyrière, Didier Autran, Michel Kalamarides, Pierre-Hugues Roche, Stéphane Fuentes, Emeline Tabouret, Maryline Barrie, Chantal Campello, Ahmed Idbaih, Mohamed Boucekine, Dominique Figarella-Branger, Anne Barlier, Henry Dufour, Olivier Chinot
Journal: Neuro-Oncology (2017)

After iterative surgeries and radiotherapy (RT)/radiosurgery (RS) failure, aggressive meningiomas remain an unmet medical need. We have shown in vitro that everolimus combined to octreotide is active in meningiomas. Prospective multicentric single arm phase II study (NCT02333565) including patients with recurrent meningioma with documented progression (>10% increase of tumor surface over 6 months) after surgery and RT/RS. Everolimus was orally administrated at 10mg/day and octreotide by IM injection 30 mg/28 days. MRI was performed every 3 months with preplanned central review of imaging. The primary endpoint was PFS6. The criteria for success was defined as a PFS6> 40%. 20 patients were included, aged 30-75 years with 37 progressive intracranial meningiomas (16 non-NF2 patients: 2 WHO grade I, 7 grade II, 7 grade III; and 4 NF2 patients). All patients previously underwent at least one surgery. 19/20 patients were treated with RT/RS and 5 pts with prior chemotherapy. 1 patient was not evaluable at 3 months. With a median follow-up of 14.3 months (2-24 months), PFS6 was 58.2% (95% CI33.5-76.5%) and PFS12 was 38% (95% CI16-60%). Overall survival at 12 months was 68% (95% CI42.1%-84.2%). By central review, volumetric analysis at 3 months demonstrated a decrease in tumor volume superior to 10% in 8 tumors (4 patients). Pretherapeutic growth rate was decreased of more than 50% in 29/35 tumors (18/20 patients) during the first 3 months. Inclusion-to-3 months tumor growth rate (mean at 1.9%/month) was significantly lower than preinclusion-to-inclusion growth rate (mean at 18.5%/month) (p=0.0003). Toxicity included stomatitis (10, 50%) and 7 grade III AE (stomatitis, 3; pneumopathy, 1). SST2 receptor expression was not correlated with PFS and growth rate. P70 IHC and genomic studies are ongoing. Everolimus and octreotide combination appears active in refractory aggressive and progressive meningiomas with moderate toxicity, and should request further evaluation.
Manejo de la fiebre de Lassa en los países europeos
Authors: N Crowcroft
Journal: Eurosurveillance (2002)

En noviembre de 2000, el Servicio de Laboratorio de la Salud Publica (Public Health Laboratory Service) celebro una reunion en Londres para discutir la forma de abordar el problema de la fiebre de Lassa a raiz de los cuatro casos producidos en 1999/2000. Los participantes fueron invitados porque habian participado recientemente en el manejo clinico y microbiologico de los casos de fiebre de Lassa o en los aspectos sanitarios de un caso de esta infeccion. Al finalizar la reunion se procedio a un analisis libre y franco de los asuntos mas confidenciales. Este informe recoge los temas generales y las recomendaciones formuladas durante dicha reunion.
Desarrollo de un protocolo para evaluar la calidad de los datos de la gripe recogidos por los médicos centinela en Europa
Authors: M Valette, M Aymard
Journal: Eurosurveillance (2002)

El EISS implanto un protocolo de evaluacion para valorar la calidad de los datos clinicos recogidos por redes centinela dedicadas a la vigilancia de la gripe. El protocolo fue aplicado en Belgica y tres regiones de Espana, dando lugar a la formulacion de recomendaciones para mejorar las redes de vigilancia nacionales y regionales.
Alendronate and Hip Fracture in Patients Using Glucocorticoids—Reply
Authors: Kristian F. Axelsson, Anna G. Nilsson, Mattias Lorentzon
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
P1.14-010 SGA Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients Treated by Concurrent Chemoradiotherapy
Authors: L. Ma, W. Ye, Q. Li, B. Wang, G. Luo, Z. Chen, S. Guo, B. Qiu, H. Liu
Journal: Journal of Thoracic Oncology (2017)
P3.04-011 A Prospective Study to Optimize the Extent of Pulmonary Resection According to Decision-Making Algorithm in cStage IA NSCLC
Authors: H.K. Kim, H.Y. Lee, Y. Choi, H. Kim, K. Lee, S. Shin, J.H. Cho, Y.S. Choi, J. Kim, J.I. Zo, Y.M. Shim
Journal: Journal of Thoracic Oncology (2017)